pubmed-article:16770770 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:16770770 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:16770770 | lifeskim:mentions | umls-concept:C0473169 | lld:lifeskim |
pubmed-article:16770770 | lifeskim:mentions | umls-concept:C0392050 | lld:lifeskim |
pubmed-article:16770770 | lifeskim:mentions | umls-concept:C0016410 | lld:lifeskim |
pubmed-article:16770770 | lifeskim:mentions | umls-concept:C0220825 | lld:lifeskim |
pubmed-article:16770770 | lifeskim:mentions | umls-concept:C0205390 | lld:lifeskim |
pubmed-article:16770770 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
pubmed-article:16770770 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:16770770 | pubmed:dateCreated | 2006-8-14 | lld:pubmed |
pubmed-article:16770770 | pubmed:abstractText | It has been previously observed that patients with head and neck squamous cell carcinoma or with laryngeal leucoplakia present a significant reduction in plasma folate levels. The current Phase IIA pilot study assessed the effectiveness of folic acid as a chemopreventive agent in patients affected by glottic laryngeal leucoplakia. | lld:pubmed |
pubmed-article:16770770 | pubmed:language | eng | lld:pubmed |
pubmed-article:16770770 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16770770 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:16770770 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16770770 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:16770770 | pubmed:month | Jul | lld:pubmed |
pubmed-article:16770770 | pubmed:issn | 0008-543X | lld:pubmed |
pubmed-article:16770770 | pubmed:author | pubmed-author:MauriziMauriz... | lld:pubmed |
pubmed-article:16770770 | pubmed:author | pubmed-author:NavarraPierlu... | lld:pubmed |
pubmed-article:16770770 | pubmed:author | pubmed-author:GiardinaBruno... | lld:pubmed |
pubmed-article:16770770 | pubmed:author | pubmed-author:PaludettiGaet... | lld:pubmed |
pubmed-article:16770770 | pubmed:author | pubmed-author:AlmadoriGiova... | lld:pubmed |
pubmed-article:16770770 | pubmed:author | pubmed-author:BussuFrancesc... | lld:pubmed |
pubmed-article:16770770 | pubmed:author | pubmed-author:GalliJacopoJ | lld:pubmed |
pubmed-article:16770770 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:16770770 | pubmed:day | 15 | lld:pubmed |
pubmed-article:16770770 | pubmed:volume | 107 | lld:pubmed |
pubmed-article:16770770 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:16770770 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:16770770 | pubmed:pagination | 328-36 | lld:pubmed |
pubmed-article:16770770 | pubmed:meshHeading | pubmed-meshheading:16770770... | lld:pubmed |
pubmed-article:16770770 | pubmed:meshHeading | pubmed-meshheading:16770770... | lld:pubmed |
pubmed-article:16770770 | pubmed:meshHeading | pubmed-meshheading:16770770... | lld:pubmed |
pubmed-article:16770770 | pubmed:meshHeading | pubmed-meshheading:16770770... | lld:pubmed |
pubmed-article:16770770 | pubmed:meshHeading | pubmed-meshheading:16770770... | lld:pubmed |
pubmed-article:16770770 | pubmed:meshHeading | pubmed-meshheading:16770770... | lld:pubmed |
pubmed-article:16770770 | pubmed:meshHeading | pubmed-meshheading:16770770... | lld:pubmed |
pubmed-article:16770770 | pubmed:meshHeading | pubmed-meshheading:16770770... | lld:pubmed |
pubmed-article:16770770 | pubmed:meshHeading | pubmed-meshheading:16770770... | lld:pubmed |
pubmed-article:16770770 | pubmed:meshHeading | pubmed-meshheading:16770770... | lld:pubmed |
pubmed-article:16770770 | pubmed:meshHeading | pubmed-meshheading:16770770... | lld:pubmed |
pubmed-article:16770770 | pubmed:meshHeading | pubmed-meshheading:16770770... | lld:pubmed |
pubmed-article:16770770 | pubmed:year | 2006 | lld:pubmed |
pubmed-article:16770770 | pubmed:articleTitle | Pilot phase IIA study for evaluation of the efficacy of folic acid in the treatment of laryngeal leucoplakia. | lld:pubmed |
pubmed-article:16770770 | pubmed:affiliation | Institute of Otolaryngology, Universita Cattolica del Sacro Cuore, Policlinico A. Gemelli, Rome, Italy. almgio@yahoo.it | lld:pubmed |
pubmed-article:16770770 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:16770770 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |